Clinical trial
Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
NCT00066742 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00066742 |
|---|---|
| Title | Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer |
| Official title | A Phase II Study of Tirapazamine (NSC-130181)/Cisplatin/Etoposide and Concurrent Thoracic Radiotherapy for Limited Stage Small Cell Lung Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Limited Stage Small Cell Lung Cancer |
| Intervention type | Drug, Other, Radiation |
| Interventions | tirapazamine, cisplatin, etoposide, radiation therapy, laboratory biomarker analysis |
| Enrollment | 72 |
| Start date | Sep 1, 2003 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Aug 7, 2003 |
| Last update posted | May 15, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: